Cyanotech (OTCMKTS:CYAN) Announces Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) announced its quarterly earnings results on Monday. The biotechnology company reported $999.00 EPS for the quarter, Zacks reports. Cyanotech had a negative return on equity of 21.74% and a negative net margin of 7.14%.

Cyanotech Price Performance

OTCMKTS CYAN remained flat at $0.52 during trading hours on Monday. 3 shares of the company were exchanged, compared to its average volume of 1,013. The company’s 50 day simple moving average is $0.43 and its two-hundred day simple moving average is $0.41. The firm has a market capitalization of $3.84 million, a PE ratio of -2.08 and a beta of 0.15. Cyanotech has a 1-year low of $0.21 and a 1-year high of $0.57. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.29 and a current ratio of 1.01.

Cyanotech Company Profile

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.